# Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC

> **NCT03494803** · — · WITHDRAWN · sponsor: **HKGepitherapeutics**

## Conditions studied

- Prostate Cancer
- Prostate Adenocarcinoma
- Prostate Cancer Metastatic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03494803
- **Lead sponsor:** HKGepitherapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-06-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants enrolled, leading to insufficient patient numbers to initiate the clinical trial.
- **Last updated:** 2023-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03494803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03494803, "Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03494803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*